Reflection paper on expectations for electronic source ...
This document is a Reflection paper (reference to Guideline on Guidelines) of the GCP Inspectors Working Group. The paper is intended to cover the creation/capture of electronic clinical data in all clinical trials in the EU/EEA or in third countries in case the clinical trial reports are submitted as part of
Download Reflection paper on expectations for electronic source ...
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
Guideline Sponsors Responsibilities IMP handling and ...
www.ema.europa.euGood Clinical Practice and Good Manufacturing Practice 8 . Draft . Adopted by GCP Inspectors Working Group (GCP IWG) 28 November 2017 . Adopted by GMPD Inspectors Working Group (GMPD IWG) 5 December 2017 : Consultation of the European Commission Ad Hoc Group On Clinical Trials :
Health and Safety Executive Safe working and the ...
www.hse.gov.ukSafe working and the prevention of infection in clinical laboratories and similar facilities Page 4 of 69 Health and Safety Executive Labelling, transport and reception of specimens 35 Information 35 Transport 35 Reception of specimens at the laboratory 37 Cleaning, decontamination and waste disposal 38 Cleaning and decontamination 38 Disposal of laboratory waste 39